Patrick Jacobs

Vice President of sales at NanoCellect. Their mission is to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more portable, affordable, and easier to use. Use microfluidics to make flow cytometers that enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, or basic research. NanoCellect's game changing technology offers unique solutions to barriers imposed by current state of the art flow cytometers. Use microfluidics with an integrated sorting system that immensely simplifies the process of analyzing and sorting distinct populations of cells from a heterogeneous population. NanoCellect Biomedical, Inc. changed its name September 2012 and was previously NanoSort, Inc. ----- NanoCellect Biomedical, Inc. aims to make flow cytometry and cell sorting technology more affordable and accessible for life science researchers to perform cellular analysis, develop molecular diagnostics, and improve personalized medicine. A critical element for biomedical research is the ability for scientists to analyze and isolate cells using flow cytometers. Scientists use flow cytometers to obtain a fast, objective and quantitative recording of fluorescent signals from individual cells as well as physical separation of cells of particular interest. NanoCellect's mission is to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more portable, affordable, and easier to use. We use microfluidics to make flow cytometers that enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, or basic research. ----- Obtaining a homogenous population of cells from a complex mixture is essential for improved downstream applications like QPCR, genomics, and imaging. Fluorescence Activated Cell Sorters (FACS) analyze and sort thousands of cells per minute and are essential systems for most biomedical research labs ($1B instrument market). NanoCellect was spunout from UCSD to commercialize a disruptive technology for analyzing and sorting cells at 1/5th the cost of current systems. The initial product, WOLF Cell Sorter is a small, affordable, and easy-to-use bench-top cell sorter with features and performance comparable to high-end complex flow cytometers that are primarily found in shared core facilities. The platform is accompanied by disposable microfluidic chips that makes setup and sorting easier while reducing contamination and improving cell viability during sorting. Since inception, NanoCellect has won 8 grants and contracts from the NIH for over $6.1M in non-dilutional funding.